[Intraoperative use of activated recombinant factor VII in a patient with brain cancer].
Cassinello Ogea
C
C
Cotera Usúa
I
I
Cortés Franco
S
S
Félix Lucía
J
J
D054058:Acute Coronary Syndrome / Q000150:complications; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D016913:Blood Component Transfusion; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D002395:Catecholamines / Q000378:metabolism; D002543:Cerebral Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D000075202:Contraindications; D015942:Factor VIIa / Q000627:therapeutic use*; D005260:Female; D006488:Hemostasis, Surgical / Q000379:methods*; D006801:Humans; D007431:Intraoperative Complications / Q000209:etiology / Q000517:prevention & control*; D008577:Meningeal Neoplasms / Q000098:blood supply / Q000150:complications / Q000601:surgery*; D008579:Meningioma / Q000098:blood supply / Q000150:complications / Q000601:surgery*; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary / Q000150:complications; D010235:Paraganglioma / Q000150:complications / Q000378:metabolism; D011994:Recombinant Proteins / Q000627:therapeutic use
D000925:Anticoagulants; D002395:Catecholamines; D011994:Recombinant Proteins; C103587:recombinant FVIIa; D015942:Factor VIIa